| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.15 | 0.5 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |